KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Operating Expenses (2017 - 2025)

Twist Bioscience (TWST) has disclosed Other Operating Expenses for 6 consecutive years, with -$5.9 million as the latest value for Q3 2023.

  • On a quarterly basis, Other Operating Expenses fell 603.66% to -$5.9 million in Q3 2023 year-over-year; TTM through Sep 2023 was -$1000.0, a 100.01% decrease, with the full-year FY2022 number at $14.2 million, up 2567.6% from a year prior.
  • Other Operating Expenses was -$5.9 million for Q3 2023 at Twist Bioscience, down from $581000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $17.6 million in Q3 2020 to a low of -$28.6 million in Q2 2020.
  • A 5-year average of $3.9 million and a median of $4.1 million in 2022 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 324.22% in 2022, then plummeted 603.66% in 2023.
  • Twist Bioscience's Other Operating Expenses stood at $13.8 million in 2019, then increased by 27.44% to $17.6 million in 2020, then plummeted by 83.92% to $2.8 million in 2021, then skyrocketed by 46.32% to $4.1 million in 2022, then tumbled by 243.0% to -$5.9 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Other Operating Expenses are -$5.9 million (Q3 2023), $581000.0 (Q2 2023), and $1.2 million (Q1 2023).